Natera Gross Profit 2014-2025 | NTRA
Natera annual/quarterly gross profit history and growth rate from 2014 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Natera gross profit for the quarter ending September 30, 2025 was $0.384B, a 41.45% increase year-over-year.
- Natera gross profit for the twelve months ending September 30, 2025 was $1.347B, a 52.53% increase year-over-year.
- Natera annual gross profit for 2024 was $1.023B, a 107.65% increase from 2023.
- Natera annual gross profit for 2023 was $0.493B, a 35.38% increase from 2022.
- Natera annual gross profit for 2022 was $0.364B, a 18.53% increase from 2021.
|
Natera Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $1,023 |
| 2023 | $493 |
| 2022 | $364 |
| 2021 | $307 |
| 2020 | $187 |
| 2019 | $127 |
| 2018 | $92 |
| 2017 | $70 |
| 2016 | $77 |
| 2015 | $78 |
| 2014 | $81 |
| 2013 | $18 |
|
Natera Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-09-30 | $384 |
| 2025-06-30 | $347 |
| 2025-03-31 | $317 |
| 2024-12-31 | $300 |
| 2024-09-30 | $272 |
| 2024-06-30 | $243 |
| 2024-03-31 | $209 |
| 2023-12-31 | $160 |
| 2023-09-30 | $121 |
| 2023-06-30 | $118 |
| 2023-03-31 | $94 |
| 2022-12-31 | $90 |
| 2022-09-30 | $94 |
| 2022-06-30 | $89 |
| 2022-03-31 | $91 |
| 2021-12-31 | $79 |
| 2021-09-30 | $77 |
| 2021-06-30 | $66 |
| 2021-03-31 | $86 |
| 2020-12-31 | $52 |
| 2020-09-30 | $46 |
| 2020-06-30 | $40 |
| 2020-03-31 | $49 |
| 2019-12-31 | $39 |
| 2019-09-30 | $34 |
| 2019-06-30 | $31 |
| 2019-03-31 | $24 |
| 2018-12-31 | $24 |
| 2018-09-30 | $24 |
| 2018-06-30 | $22 |
| 2018-03-31 | $22 |
| 2017-12-31 | $15 |
| 2017-09-30 | $21 |
| 2017-06-30 | $18 |
| 2017-03-31 | $16 |
| 2016-12-31 | $7 |
| 2016-09-30 | $20 |
| 2016-06-30 | $21 |
| 2016-03-31 | $30 |
| 2015-12-31 | $21 |
| 2015-09-30 | $14 |
| 2015-06-30 | $19 |
| 2015-03-31 | $23 |
| 2014-12-31 | |
| 2014-09-30 | $25 |
| 2014-06-30 | $17 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $32.485B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $165.519B | 30.39 |
| HCA Healthcare (HCA) | United States | $105.969B | 17.54 |
| CVS Health (CVS) | United States | $101.669B | 11.69 |
| Elevance Health (ELV) | United States | $81.575B | 11.96 |
| Cencora (COR) | United States | $68.028B | 21.93 |
| DiDi Global (DIDIY) | China | $22.874B | 21.13 |
| Labcorp Holdings (LH) | United States | $22.492B | 17.15 |
| Medpace Holdings (MEDP) | United States | $16.969B | 42.13 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.166B | 0.00 |
| Viatris (VTRS) | United States | $14.581B | 5.43 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| ICON (ICLR) | Ireland | $14.259B | 14.15 |
| Solventum (SOLV) | United States | $13.695B | 13.29 |
| Revvity (RVTY) | United States | $12.686B | 23.36 |
| CochLear (CHEOY) | Australia | $11.814B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.738B | 20.68 |
| Avantor (AVTR) | United States | $8.080B | 12.34 |
| Sonic Healthcare (SKHHY) | Australia | $7.695B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.412B | 0.00 |
| HealthEquity (HQY) | United States | $7.177B | 26.84 |
| BrightSpring Health Services (BTSG) | United States | $6.985B | 41.65 |
| Bausch + Lomb (BLCO) | Canada | $6.053B | 39.74 |
| PACS (PACS) | United States | $5.590B | 33.99 |
| Sotera Health (SHC) | United States | $5.310B | 25.60 |
| Alignment Healthcare (ALHC) | United States | $4.550B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.881B | 50.60 |
| Concentras Parent (CON) | United States | $2.808B | 17.53 |
| Organon (OGN) | United States | $2.459B | 2.59 |
| Progyny (PGNY) | United States | $2.188B | 43.02 |
| Surgery Partners (SGRY) | United States | $2.022B | 26.05 |
| Establishment Labs Holdings (ESTA) | United States | $1.878B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.866B | 11.14 |
| Ardent Health (ARDT) | United States | $1.188B | 3.88 |
| Nutex Health (NUTX) | United States | $1.087B | 8.32 |
| Teladoc Health (TDOC) | United States | $1.077B | 0.00 |
| CareDx (CDNA) | United States | $1.039B | 16.98 |
| Omada Health (OMDA) | United States | $0.911B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.883B | 14.44 |
| InnovAge Holding (INNV) | United States | $0.806B | 0.00 |
| Embecta (EMBC) | United States | $0.728B | 4.14 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.702B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.590B | 0.00 |
| CryoPort (CYRX) | United States | $0.538B | 0.00 |
| Enhabit (EHAB) | United States | $0.528B | 23.70 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.496B | 0.00 |
| SBC Medicals (SBC) | United States | $0.440B | 8.09 |
| Agilon Health (AGL) | United States | $0.405B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.338B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.302B | 63.60 |
| Shoulder Innovations (SI) | United States | $0.290B | 0.00 |
| So-Young (SY) | China | $0.270B | 0.00 |
| KindlyMD (NAKA) | United States | $0.185B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| LifeMD (LFMD) | United States | $0.171B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.134B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.125B | 0.00 |
| DocGo (DCGO) | United States | $0.079B | 0.00 |
| Biodesix (BDSX) | United States | $0.071B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.064B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.24 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.017B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.014B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.006B | 0.00 |
| Pheton Holdings (ITOC) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |